US-based Implant Sciences has delivered 178 of its QS-B220 desktop explosives trace detectors (ETDs) to all three major airports in Paris.
The QS-B220 uses ion mobility spectrometry (IMS) to detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Over the past few months, the company has secured a series of tenders in France, as well as across the European Union (EU).
After securing two recent airport tenders in France, the company’s ETDs have now been deployed to more than 95% of major French airports, that handle over 500,000 passengers per year.
Implant Sciences Global Sales and Marketing vice-president Dr Darryl Jones said: "We have announced, combined with our contracts with the Union of French Airports (UAF) and Nice, a total of up to 507 QS-B220s sold to French airports over the last three months, and up to 783 altogether across the EU.
"We believe that there is additional opportunity for our systems over the next several years in France, as well as across the rest of Europe, as the EU ETD regulations for airports with fewer than 500,000 passengers are set to be implemented after the major airports’ installation of ETDs is complete.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"The European market is as important to our expanding growth as the opportunity domestically is with the TSA, and we are pleased that our technology continues to receive favourable market acceptance."
Compared to competing systems, the QS-B220 claims to require less maintenance, and it can be deployed for a much lower total cost of ownership.
The QS-B220 features a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system.
Implant Sciences EMEA general manager Richard Nelson said: "This is our third major contract in France.
"French airports have repeatedly chosen Implant Sciences over the competition because of our unparalleled non-rad expertise and superior product offering.
"We believe that our competitors simply cannot match our systems’ performance and value. When tested side by side, our low false alarm rate and system reliability demonstrate why the QS-B220 has been chosen by key aviation customers worldwide, including French airports, the majority of other ECAC-driven European aviation security buyers, and, of course, the TSA in the US."
